A protein facilitating DNA replication during cell cycle also binds microtubules, findings that could inform more effective cancer treatments, according to a recent study published in the Journal of Cell Biology.
The three-dimensional atomic structure of the epigenetic driver COMPASS was solved for the first time in a study published in the journal Cell.
A drug called mogamulizumab significantly improved progression-free survival for patients with cutaneous T-cell lymphoma, according to a study published in The Lancet Oncology.
A bill based in part on research and advocacy at Northwestern amends the Illinois insurance code to require oncofertility coverage, which requires insurance to cover fertility preservation.
The Robert H. Lurie Comprehensive Cancer Center has been awarded a new, five-year $11.5 million grant from the National Cancer Institute to advance translational brain cancer research.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has been renewed for a fourth five-year grant, totaling $31.5 million and representing a 36 percent increase over its previous funding.
Northwestern Medicine scientists are using a variety of innovative techniques to uncover the epigenetics of breast cancer, as seen in three recent studies.
Ali Shilatifard, PhD, has been appointed editor of Science Advances, an open-access journal published by the American Association for the Advancement of Science, which also publishes the journal Science.
Two Northwestern faculty, including the chair of Pathology, will serve as president and vice president of the American Association of Neuropathologists.
Melissa Simon, MD, MPH, the George H. Gardner Professor of Clinical Gynecology, has received the National Science Foundation’s Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring.